1. |
Finkelstein EA, Khavjou OA, Thompson H, et al. Obesity and severe obesity forecasts through 2030. Am J Prev Med, 2012, 42(6): 563-570.
|
2. |
Ward ZJ, Bleich SN, Cradock AL, et al. Projected U. S. state-level prevalence of adult obesity and severe obesity. N Engl J Med, 2019, 381(25): 2440-2450.
|
3. |
Sturm R, Hattori A. Morbid obesity rates continue to rise rapidly in the United States. Int J Obes (Lond), 2013, 37(6): 889-891.
|
4. |
Ohta M, Seki Y, Wong SK, et al. Bariatric/metabolic surgery in the Asia-Pacific region: APMBSS 2018 survey. Obes Surg, 2019, 29(2): 534-541.
|
5. |
Lauti M, Kularatna M, Hill AG, et al. Weight regain following sleeve gastrectomy—a systematic review. Obes Surg, 2016, 26(6): 1326-1334.
|
6. |
Bakr AA, Fahmy MH, Elward AS, et al. Analysis of medium-term weight regain 5 years after laparoscopic sleeve gastrectomy. Obes Surg, 2019, 29(11): 3508-3513.
|
7. |
Nedelcu M, Loureiro M, Skalli M, et al. Laparoscopic sleeve gastrectomy: effect on long-term remission for morbidly obese patients with type 2 diabetes at 5-year follow up. Surgery, 2017, 162(4): 857-862.
|
8. |
Sudan R, Jain-Spangler K. Tailoring bariatric surgery: sleeve gastrectomy, Roux-en-Y gastric bypass and biliopancreatic diversion with duodenal switch. J Laparoendosc Adv Surg Tech A, 2018, 28(8): 956-961.
|
9. |
Cosentino C, Marchetti C, Monami M, et al. Efficacy and effects of bariatric surgery in the treatment of obesity: network meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis, 2021, 31(10): 2815-2824.
|
10. |
Kapeluto JE, Tchernof A, Masckauchan D, et al. Ten-year remission rates in insulin-treated type 2 diabetes after biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis, 2020, 16(11): 1701-1712.
|
11. |
Nett P, Borbély Y, Kröll D. Micronutrient supplementation after biliopancreatic diversion with duodenal switch in the long term. Obes Surg, 2016, 26(10): 2469-2474.
|
12. |
Strain GW, Torghabeh MH, Gagner M, et al. The impact of biliopancreatic diversion with duodenal switch (BPD/DS) over 9 years. Obes Surg, 2017, 27(3): 787-794.
|
13. |
Roth AE, Thornley CJ, Blackstone RP. Outcomes in bariatric and metabolic surgery: an updated 5-year review. Curr Obes Rep, 2020, 9(3): 380-389.
|
14. |
Merz AE, Blackstone RB, Gagner M, et al. Duodenal switch in revisional bariatric surgery: conclusions from an expert consensus panel. Surg Obes Relat Dis, 2019, 15(6): 894-899.
|
15. |
Yashkov Y, Bordan N, Torres A, et al. SADI-S 250 vs Roux-en-Y duodenal switch (RY-DS): results of 5-year observational study. Obes Surg, 2021, 31(2): 570-579.
|
16. |
Lebel S, Dion G, Marceau S, et al. Clinical outcomes of duodenal switch with a 200-cm common channel: a matched, controlled trial. Surg Obes Relat Dis, 2016, 12(5): 1014-1020.
|
17. |
Zhang M, Lv XY, Li J, et al. The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp Diabetes Res, 2008, 2008: 704045. doi: 10.1155/2008/704045.
|
18. |
Liu P, Widjaja J, Dolo PR, et al. Comparing the anti-diabetic effect of sleeve gastrectomy with transit bipartition against sleeve gastrectomy and Roux-en-Y gastric bypass using a diabetic rodent model. Obes Surg, 2021, 31(5): 2203-2210.
|
19. |
Biertho L, Lebel S, Marceau S, et al. Biliopancreatic diversion with duodenal switch: surgical technique and perioperative care. Surg Clin North Am, 2016, 96(4): 815-826.
|
20. |
Hutch CR, Sandoval D. The role of GLP-1 in the metabolic success of bariatric surgery. Endocrinology, 2017, 158(12): 4139-4151.
|
21. |
Sandoval D. CNS GLP-1 regulation of peripheral glucose homeostasis. Physiol Behav, 2008, 94(5): 670-674.
|
22. |
Ramos-Leví AM, Sánchez-Pernaute A, Marcuello C, et al. Glucose variability after bariatric surgery: is prediction of diabetes remission possible? Obes Surg, 2017, 27(12): 3341-3343.
|
23. |
Santoro S, Mota FC, Aquino CG. Treating severe GERD and obesity with a sleeve gastrectomy with cardioplication and a transit bipartition. Obes Surg, 2019, 29(4): 1439-1441.
|
24. |
Santoro S, Lacombe A, Aquino CG, et al. Sleeve gastrectomy with anti-reflux procedures. Einstein (Sao Paulo), 2014, 12(3): 287-294.
|
25. |
Vieth M, Peitz U, Labenz J, et al. What parameters are relevant for the histological diagnosis of gastroesophageal reflux disease without Barrett’s mucosa? Dig Dis, 2004, 22(2): 196-201.
|
26. |
Ismail-Beigi F, Horton PF, Pope CE 2nd. Histological consequences of gastroesophageal reflux in man. Gastroenterology, 1970, 58(2): 163-174.
|
27. |
Guimarães AGC, Lopes LES, Capelassi AN, et al. Morphological alterations in gastrointestinal organs of western-diet obese rats submitted to vertical sleeve gastrectomy or Roux-en-Y gastric bypass. An Acad Bras Cienc, 2021, 93(4): e20200884. doi: 10.1590/0001-3765202120200884.
|
28. |
van Beek AP, Emous M, Laville M, et al. Dumping syndrome after esophageal, gastric or bariatric surgery: pathophysiology, diagnosis, and management. Obes Rev, 2017, 18(1): 68-85.
|
29. |
Santoro S, Castro LC, Velhote MC, et al. Sleeve gastrectomy with transit bipartition: a potent intervention for metabolic syndrome and obesity. Ann Surg, 2012, 256(1): 104-110.
|
30. |
Rodrigo DC, Jill S, Daniel M, et al. Which factors correlate with marginal ulcer after surgery for obesity? Obes Surg, 2020, 30(12): 4821-4827.
|
31. |
Mahdy T, Al Wahedi A, Schou C. Efficacy of single anastomosis sleeve ileal (SASI) bypass for type-2 diabetic morbid obese patients: gastric bipartition, a novel metabolic surgery procedure: a retrospective cohort study. Int J Surg, 2016, 34: 28-34.
|